Aureka Biotechnologies Secures $35M Series A+ Financing to Advance AuraIDE Platform for Functional Antibody Design
Aureka Biotechnologies, a global leader in the Tech-Bio space, announced the completion of its Series...
Aureka Biotechnologies
Aureka Biotechnologies Closes Multi‑Million‑Dollar Series A – Generative Antibody Platform Gains 5Y Capital & Qiming Backing
Aureka Biotechnologies, a pioneer in generative antibody drug development, announced today the successful close of...
Aureka Biotechnologies Secures $10 Million in Seed Funding for AI-Driven Biotechnology
Aureka Biotechnologies Inc., a California-based artificial intelligence (AI)-empowered biotech company, has successfully raised USD 10...